The reduction in immunogenicity of neurotrophin overexpressing stem cells after intra-striatal transplantation by encapsulation in an in situ gelling collagen hydrogel.

[1]  B. Newland,et al.  Biomaterial approaches to gene therapies for neurodegenerative disorders of the CNS. , 2013, Biomaterials science.

[2]  B. Newland,et al.  GDNF gene delivery via a 2-(dimethylamino)ethyl methacrylate based cyclized knot polymer for neuronal cell applications. , 2013, ACS chemical neuroscience.

[3]  B. Newland,et al.  The neurotoxicity of gene vectors and its amelioration by packaging with collagen hollow spheres. , 2013, Biomaterials.

[4]  D. Hoban,et al.  Further characterisation of the LPS model of Parkinson’s disease: A comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat , 2013, Brain, Behavior, and Immunity.

[5]  A. Windebank,et al.  The effect of intraluminal contact mediated guidance signals on axonal mismatch during peripheral nerve repair. , 2012, Biomaterials.

[6]  Herman Goossens,et al.  Cell Type-Associated Differences in Migration, Survival, and Immunogenicity following Grafting in CNS Tissue , 2012, Cell transplantation.

[7]  S. Dunnett,et al.  Long-term expansion of human foetal neural progenitors leads to reduced graft viability in the neonatal rat brain , 2012, Experimental Neurology.

[8]  Yu Jin Lee,et al.  Functional recovery after spinal cord injury in dogs treated with a combination of Matrigel and neural-induced adipose-derived mesenchymal Stem cells. , 2012, Cytotherapy.

[9]  R. Kamble,et al.  Bilateral Transplantation of Allogenic Adult Human Bone Marrow-Derived Mesenchymal Stem Cells into the Subventricular Zone of Parkinson's Disease: A Pilot Clinical Study , 2012, Stem cells international.

[10]  B. Newland,et al.  The reverse of polymer degradation: in situ crosslinked gel formation through disulfide cleavage. , 2012, Chemical communications.

[11]  S. Carmichael,et al.  Physically Associated Synthetic Hydrogels with Long‐Term Covalent Stabilization for Cell Culture and Stem Cell Transplantation , 2011, Advanced materials.

[12]  William Shain,et al.  The fate of ultrafast degrading polymeric implants in the brain. , 2011, Biomaterials.

[13]  A. Linden,et al.  Recognition of cellular implants by the brain's innate immune system , 2011, Immunology and cell biology.

[14]  M. Sefton,et al.  Functionalized scaffold-mediated interleukin 10 gene delivery significantly improves survival rates of stem cells in vivo. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  Pierre Weiss,et al.  An injectable vehicle for nucleus pulposus cell-based therapy. , 2011, Biomaterials.

[16]  D. Finn,et al.  Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson's disease in the rat , 2011, Neuroscience.

[17]  F. Barry,et al.  Potential of rat bone marrow-derived mesenchymal stem cells as vehicles for delivery of neurotrophins to the Parkinsonian rat brain , 2010, Brain Research.

[18]  M. Mahoney,et al.  Biocompatibility of poly(ethylene glycol)-based hydrogels in the brain: an analysis of the glial response across space and time. , 2010, Journal of biomedical materials research. Part A.

[19]  Michael J Yaszemski,et al.  Controlling dispersion of axonal regeneration using a multichannel collagen nerve conduit. , 2010, Biomaterials.

[20]  B. Newland,et al.  Dual stimuli responsive PEG based hyperbranched polymers , 2010 .

[21]  S. Carmichael,et al.  Hydrogel Matrix to Support Stem Cell Survival After Brain Transplantation in Stroke , 2010, Neurorehabilitation and neural repair.

[22]  F. Barry,et al.  Survival and Immunogenicity of Mesenchymal Stem Cells From the Green Fluorescent Protein Transgenic Rat in the Adult Rat Brain , 2010, Neurorehabilitation and neural repair.

[23]  S. Totey,et al.  Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease. , 2010, Translational research : the journal of laboratory and clinical medicine.

[24]  Carsten Werner,et al.  A star-PEG-heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases. , 2009, Biomaterials.

[25]  J. Takahashi,et al.  Matrigel supports survival and neuronal differentiation of grafted embryonic stem cell‐derived neural precursor cells , 2009, Journal of neuroscience research.

[26]  D. Joseph,et al.  Dissection, plating, and maintenance of cortical astrocyte cultures. , 2009, Cold Spring Harbor protocols.

[27]  F. Barry,et al.  Neurotrophic factor-expressing mesenchymal stem cells survive transplantation into the contused spinal cord without differentiating into neural cells. , 2009, Tissue engineering. Part A.

[28]  A. P. Robinson,et al.  Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses , 2008, Proceedings of the National Academy of Sciences.

[29]  R. G. Paul,et al.  Factors influencing the properties of reconstituted collagen fibers prior to self-assembly: animal species and collagen extraction method. , 2008, Journal of biomedical materials research. Part A.

[30]  Ping Chen,et al.  Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue. , 2008, Stem cells and development.

[31]  M. Tuszynski,et al.  Therapeutic potential of CERE-110 (AAV2-NGF): Targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons , 2008, Experimental Neurology.

[32]  R. Bakay,et al.  Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial , 2008, The Lancet Neurology.

[33]  Suping Wang,et al.  Isolation and characterization of mesenchymal stem cells derived from bone marrow of patients with Parkinson’s disease , 2008, In Vitro Cellular & Developmental Biology - Animal.

[34]  Dirk Strunk,et al.  Two steps to functional mesenchymal stromal cells for clinical application , 2007, Transfusion.

[35]  Q. Xu,et al.  Hyaluronic acid hydrogel immobilized with RGD peptides for brain tissue engineering , 2006, Journal of materials science. Materials in medicine.

[36]  Lili Zhou,et al.  Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Dunnett,et al.  The survival of neural precursor cell grafts is influenced by in vitro expansion , 2005, Journal of anatomy.

[38]  R. Juliano,et al.  Clinging to life: cell to matrix adhesion and cell survival , 2005, Cancer and Metastasis Reviews.

[39]  H D Li,et al.  Hyaluronic acid-poly-D-lysine-based three-dimensional hydrogel for traumatic brain injury. , 2005, Tissue engineering.

[40]  R. Hamid,et al.  Comparison of alamar blue and MTT assays for high through-put screening. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[41]  M. Dragunow,et al.  AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[42]  C. Carlo-Stella,et al.  Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.

[43]  A. Harvey,et al.  The Regrowth of Axons within Tissue Defects in the CNS Is Promoted by Implanted Hydrogel Matrices That Contain BDNF and CNTF Producing Fibroblasts , 2001, Experimental Neurology.

[44]  A. Björklund,et al.  Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6‐OHDA lesion model depends on the site of administration of the trophic factor , 2000, The European journal of neuroscience.

[45]  M. Aschner,et al.  Isolation of Neonatal Rat Cortical Astrocytes for Primary Cultures , 2000, Current protocols in toxicology.

[46]  A. Harvey,et al.  Neural tissue formation within porous hydrogels implanted in brain and spinal cord lesions: ultrastructural, immunohistochemical, and diffusion studies. , 1999, Tissue engineering.

[47]  A. Björklund,et al.  Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle , 1999, The European journal of neuroscience.

[48]  Blunt,et al.  Long‐term protection of the rat nigrostriatal dopaminergic system by glial cell line‐derived neurotrophic factor against 6‐hydroxydopamine in vivo , 1998, The European journal of neuroscience.

[49]  A. Björklund,et al.  Short-Term GDNF Treatment Provides Long-Term Rescue of Lesioned Nigral Dopaminergic Neurons in a Rat Model of Parkinson’s Disease , 1996, The Journal of Neuroscience.

[50]  M. Perricaudet,et al.  Transplantation to the rat brain of human neural progenitors that were genetically modified using adenoviruses , 1995, Nature Genetics.

[51]  G. Nikkhah,et al.  Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model , 1994, Brain Research.

[52]  S. Papapetropoulos.  Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial , 2011 .

[53]  R V Bellamkonda,et al.  Polylysine-functionalised thermoresponsive chitosan hydrogel for neural tissue engineering. , 2007, Biomaterials.

[54]  Kevin McIntosh,et al.  Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. , 2002, Experimental hematology.